SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism

Elmukhtar Habas, Amnna Rayani, Ala Habas, Khaled Alarbi, Aml Habas, Mohamed Baghi, Eshrak Habas, Elmehdi Errayes, Abdelrahaman Hamad, Abdelnaser Elzouki

Open source

DOI
10.1080/0886022x.2026.2688578
Published
2026-07-02
Container
Renal Failure
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/0886022x.2026.2688578,
  title = {SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism},
  author = {Elmukhtar Habas and Amnna Rayani and Ala Habas and Khaled Alarbi and Aml Habas and Mohamed Baghi and Eshrak Habas and Elmehdi Errayes and Abdelrahaman Hamad and Abdelnaser Elzouki},
  year = {2026},
  journal = {Renal Failure},
  doi = {10.1080/0886022x.2026.2688578},
  url = {https://doi.org/10.1080/0886022x.2026.2688578}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism
AU  - Elmukhtar Habas
AU  - Amnna Rayani
AU  - Ala Habas
AU  - Khaled Alarbi
AU  - Aml Habas
AU  - Mohamed Baghi
AU  - Eshrak Habas
AU  - Elmehdi Errayes
AU  - Abdelrahaman Hamad
AU  - Abdelnaser Elzouki
PY  - 2026
JO  - Renal Failure
DO  - 10.1080/0886022x.2026.2688578
UR  - https://doi.org/10.1080/0886022x.2026.2688578
ER  - 

APA

Habas, E., Rayani, A., Habas, A., Alarbi, K., Habas, A., Baghi, M., Habas, E., Errayes, E., Hamad, A., & Elzouki, A. (2026). SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism. Renal Failure. https://doi.org/10.1080/0886022x.2026.2688578

Source records